Vincerx Pharma

$17.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.70 (-3.83%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Vincerx Pharma and other stocks, options, and ETFs commission-free!

About VINC

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.

CEO
Ahmed Hamdy
Employees
28
Headquarters
Palo Alto, California
Founded
2018
Market Cap
240.57M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
61.28K
High Today
$18.50
Low Today
$17.50
Open Price
$18.50
Volume
68.24K
52 Week High
$26.75
52 Week Low
$9.35

VINC Earnings

Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 15, Pre-Market

You May Also Like

ALUS+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure